A Computationally Designed Prefusion Stabilized Human Metapneumovirus Fusion Protein Vaccine Antigen Elicited a Potent Neutralization Response
<b>Background/Objectives:</b> Human metapneumovirus (hMPV) is a leading cause of respiratory infections in the elderly, with high morbidity and mortality and with no vaccines or specific therapies available. The primary protective antigen of hMPV is the fusion protein, and its prefusion...
Saved in:
| Main Authors: | Michael Kishko, Antonia Stuebler, Sukanya Sasmal, Yvonne Chan, Dean Huang, Christopher Reyes, Jasmine Lin, Owen Price, Ana Kume, Katie Zong, Christine Bricault, Judith Alamares-Sapuay, Linong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/5/523 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review Article: Exploring the Impact of Human Metapneumovirus: A Red Global Alarm for 2025
by: Asaad Abbas ALadlaan, et al.
Published: (2025-06-01) -
Human metapneumovirus (hMPV) in 2025: emerging trends and insights from community and hospital-based respiratory panel analyses—a comprehensive review
by: Keyhan Mohammadi, et al.
Published: (2025-05-01) -
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine Candidate
by: Maarten Swart, et al.
Published: (2024-12-01) -
Rising global threat of human metapneumovirus (hMPV in 2024/2025): pathogenesis, immune dynamics, vulnerabilities in immunocompromised individuals, and lessons from past pandemics
by: Kamoru A. Adedokun, et al.
Published: (2025-05-01) -
microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines
by: Stephen A. Leon-Icaza, et al.
Published: (2019-02-01)